EXELIXIS, INC. — Director's Dealing 2018

Mar 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2018-02-28

Reporting Person: Haley Patrick J. (Sr. Vice President, Commercial)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-28	Common Stock	M	10625	$1.76	Acquired	155519	Direct
2018-02-28	Common Stock	M	3000	$5.50	Acquired	158519	Direct
2018-02-28	Common Stock	S	45029	$27.13	Disposed	113490	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-28	Option (right to buy)	$1.76	M	10625	Disposed	2021-11-16	Common Stock (10625.0)	Direct
2018-02-28	Option (right to buy)	$5.5	M	3000	Disposed	2018-09-27	Common Stock (3000.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23539	Indirect
Common Stock	10101	Indirect

Footnotes

F1: Includes 67,602 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.03 to $27.25. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 28, 2018.

F4: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, was exercisable as to 40,625 shares as of the Transaction Date. The remainder of the option will vest as to 1/48th of the original number of shares subject to the option on each monthly anniversary of November 17, 2014 grant date.

F5: The option, representing the right to purchase a total of 3,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015.